Related Experiment Video
Updated: Jun 26, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Current status in cervical carotid artery stent placement
1Central Cardiovascular Institute of San Antonio, San Antonio, TX 78256, USA. mwholey@yahoo.com
Insights
Carotid artery stenting (CAS) offers significant benefits for high-risk symptomatic patients with extracranial carotid arterial disease. While outcomes for asymptomatic patients remain debated, CAS shows comparable or better results than carotid endarterectomy (CEA) in major trials.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Neurology
Background:
- Extracranial carotid arterial disease management is debated, with options including surgery, stenting, or medical therapy.
- Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are key interventions for preventing stroke.
Purpose of the Study:
- To review global registries and trials on CAS versus CEA for extracranial carotid arterial disease.
- To evaluate the efficacy and safety of CAS in symptomatic and asymptomatic patients.
Main Methods:
- Systematic review of carotid artery stent and endarterectomy registries and trials.
- Analysis of over 14,000 patients undergoing carotid stenting.
- Evaluation of complication rates, stroke, death, and restenosis rates.
Main Results:
- CAS demonstrates substantial benefit for high anatomic risk symptomatic patients.
- Complication rates for CAS in symptomatic patients, including octogenarians, are improving.
- Neurological outcomes, stroke, and death rates for CAS are comparable or better than CEA.
- CAS meets CMS targets for Major Adverse Events (MAE): 3% for asymptomatic and 6% for symptomatic patients.
Conclusions:
- CAS is a viable option for high-risk symptomatic patients unsuitable for medical therapy or CEA.
- The role of CAS in asymptomatic patients and octogenarians requires further investigation.
- Carotid stenting, with appropriate patient selection and experienced operators, is an effective procedure with ongoing development.
Abstract:
Based upon recent and old medical literature, with the exception of high surgical risk symptomatic patients, there remains much debate on how to manage extracranial carotid arterial disease, whether by surgical or endovascular intervention or by medical therapy alone. A review of the various global current carotid artery stent and endarterectomy registries and trials was performed incorporating more than 14,000 patients who have received carotid stents. There is substantial evidence supporting the benefit of carotid artery stenting (CAS) for the high anatomic risk population. Complication rates with symptomatic patients, including octogenarians, continue to show trend towards improvement as operators gain experience. The results are limited for standard risk carotid stenting for symptomatic patients though results with recent trials are pending but will probably show equivalence with endarterectomy. The asymptomatic patient population remains controversial: there is a small but reproducible benefit for revascularization. Long term (1-3 years) neurological results are now being reported for the major registries and trials. Analysis of target lesion revascularization, stroke and death rates of carotid stenting is comparable or better than rates for endarterectomy. Carotid artery stent placement has met the CMS targets 3% for MAE for asymptomatic patients and 6% for symptomatic patients with numerous registries and trials. CAS has also proven outcomes at 3 years with restenosis rates and stroke-free rates comparable or better than CEA. CAS provides an option for patients not suited for medical therapy and who were high-risk for CEA, especially for those symptomatic patients. It is still controversial with the role of stenting asymptomatic patients as well as for octogenarians. However, forthcoming trials will be helpful in providing more insight. Despite questionable studies and bad press, carotid stenting in the right hands with good patient selection is an excellent procedure. Finally, it is important to remember, carotid stenting is still in its early development and will only get better.
Related Concept Videos
Aneurysm IV: Nursing Management
Cardiac Catheterization IV: Nursing Management
Cardiac Catheterization III: Left Heart Catheterization
